Variant report
Variant | esv3326488 |
---|---|
Chromosome Location | chr11:32387576-32392074 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12792903 | chr11:32387578-32387579 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199721836 | chr11:32387584-32387585 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370936196 | chr11:32387585-32387586 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12792917 | chr11:32387596-32387597 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7101933 | chr11:32387617-32387618 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs186757631 | chr11:32387635-32387636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577871093 | chr11:32387661-32387662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200321974 | chr11:32387668-32387669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187179808 | chr11:32387685-32387686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191269927 | chr11:32387694-32387695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375558766 | chr11:32387700-32387701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144164761 | chr11:32387708-32387709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11031750 | chr11:32387713-32387714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572782427 | chr11:32387721-32387722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541489230 | chr11:32387722-32387723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182680314 | chr11:32387724-32387725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368268642 | chr11:32387727-32387728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377544051 | chr11:32387732-32387733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575286147 | chr11:32387733-32387734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs199739239 | chr11:32387751-32387752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187025197 | chr11:32387754-32387755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534461364 | chr11:32387773-32387774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192608967 | chr11:32387787-32387788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113078736 | chr11:32387797-32387798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367884942 | chr11:32387802-32387803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533234281 | chr11:32387803-32387804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546931803 | chr11:32387810-32387811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560473499 | chr11:32387818-32387819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372175499 | chr11:32387822-32387823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529262272 | chr11:32387826-32387827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201413284 | chr11:32387827-32387828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199689898 | chr11:32387845-32387846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141844682 | chr11:32387855-32387856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs398097463 | chr11:32387866-32387867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549153455 | chr11:32387870-32387871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569322967 | chr11:32387879-32387880 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7105538 | chr11:32387919-32387920 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs7105549 | chr11:32387936-32387937 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs571526173 | chr11:32387939-32387940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534159216 | chr11:32387956-32387957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554022670 | chr11:32387986-32387987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567912884 | chr11:32388005-32388006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7105664 | chr11:32388030-32388031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116451984 | chr11:32388184-32388185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs34772830 | chr11:32388201-32388202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs58362570 | chr11:32388208-32388209 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs544345772 | chr11:32388224-32388225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185345641 | chr11:32388240-32388241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577894315 | chr11:32388260-32388261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115258957 | chr11:32388280-32388281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Aniridia syndrome | 21572526 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Denys-drash syndrome | 21085971 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
WAGR syndrome | 16773131 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Aniridia syndrome | 17204608 | CNVD |
Mental retardation | 17204608 | CNVD |
WAGR syndrome | 19617690 | CNVD |
genitourinary abnormalities | 17204608 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 16773131 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Cancer | 21183584 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
WAGR syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Denys-drash syndrome | 19566914 | CNVD |
Familial wilms tumor | 19566914 | CNVD |
Frasier syndrome | 19566914 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
WAGR syndrome | 20603712 | CNVD |
Autism | 17322880 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Wilms tumour | 17204608 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 17440070 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:32375800-32387600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr11:32386800-32387600 | Active TSS | K562 | blood |
3 | chr11:32387600-32387800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr11:32387800-32388200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr11:32387800-32388600 | Enhancers | Ovary | ovary |
6 | chr11:32388000-32388800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr11:32388200-32388600 | Enhancers | Adipose Nuclei | Adipose |
8 | chr11:32388200-32388800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr11:32388200-32388800 | Enhancers | HepG2 | liver |
10 | chr11:32389600-32390000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |